Pushkal Garg

Insider Reports History

Entity
Individual
Location
C/O Sqz Biotechnologies Company, 200 Arsenal Yards Boulevard, Suite 210, Watertown, MA
Signature
By: Brett Budzinski, Attorney-in-Fact For: Pushkal Garg
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Pushkal Garg:

Stock Role Class Num Shares Value Price $ Report Date Ownership
ALNYLAM PHARMACEUTICALS, INC. CMO & EVP Dev & Med Affairs Common Stock 20.2K $6.07M $300.00 Mar 24, 2025 Direct
ALNYLAM PHARMACEUTICALS, INC. CMO & EVP Dev & Med Affairs Restricted Stock Units 1.91K $466K $244.11 Feb 27, 2025 Direct
ALNYLAM PHARMACEUTICALS, INC. CMO & EVP Dev & Med Affairs Common Stock 431 $129K $300.00 Mar 21, 2025 by Managed Account
ALNYLAM PHARMACEUTICALS, INC. CMO & EVP Dev & Med Affairs Common Stock 250 $75K $300.00 Mar 21, 2025 by Trust
SQZ Biotechnologies Co Director Stock Option 39.9K Jun 14, 2023 Direct
ALNYLAM PHARMACEUTICALS, INC. CMO & EVP Dev & Med Affairs Performance Stock Option 2015 (right to buy) 0 Jan 27, 2025 Direct
ALNYLAM PHARMACEUTICALS, INC. CMO & EVP Dev & Med Affairs Stock Option (right to buy) 0 Mar 24, 2025 Direct

Insider Reports Filed by Pushkal Garg

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ALNY ALNYLAM PHARMACEUTICALS, INC. Mar 21, 2025 4 -$2.64M 4 Mar 25, 2025 CMO & EVP Dev & Med Affairs
ALNY ALNYLAM PHARMACEUTICALS, INC. Mar 3, 2025 16 -$621K 4 Mar 5, 2025 CMO & EVP Dev & Med Affairs
ALNY ALNYLAM PHARMACEUTICALS, INC. Feb 27, 2025 10 -$226K 4 Mar 3, 2025 CMO & EVP Dev & Med Affairs
ALNY ALNYLAM PHARMACEUTICALS, INC. Feb 13, 2025 19 -$788K 4 Feb 18, 2025 CMO & EVP Dev & Med Affairs
ALNY ALNYLAM PHARMACEUTICALS, INC. Jan 27, 2025 5 -$10.6M 4 Jan 29, 2025 CMO & EVP Dev & Med Affairs
ALNY ALNYLAM PHARMACEUTICALS, INC. Dec 12, 2024 7 -$440K 4 Dec 13, 2024 CMO & EVP Dev & Med Affairs
ALNY ALNYLAM PHARMACEUTICALS, INC. Nov 25, 2024 6 -$422K 4 Nov 27, 2024 CMO & EVP Dev & Med Affairs
ALNY ALNYLAM PHARMACEUTICALS, INC. Oct 8, 2024 1 $0 4 Oct 10, 2024 CMO & EVP Dev & Med Affairs
ALNY ALNYLAM PHARMACEUTICALS, INC. Jun 24, 2024 13 -$486K 4 Jun 26, 2024 CMO & EVP Dev & Med Affairs
ALNY ALNYLAM PHARMACEUTICALS, INC. Mar 1, 2024 2 $0 4 Mar 5, 2024 CMO & EVP Dev & Med Affairs
ALNY ALNYLAM PHARMACEUTICALS, INC. Feb 27, 2024 7 -$89.1K 4 Feb 29, 2024 CMO & EVP Dev & Med Affairs
ALNY ALNYLAM PHARMACEUTICALS, INC. Feb 15, 2024 4 -$194K 4 Feb 20, 2024 CMO & EVP Dev & Med Affairs
ALNY ALNYLAM PHARMACEUTICALS, INC. Aug 3, 2023 11 -$1.41M 4 Aug 7, 2023 CMO & EVP Dev & Med Affairs
SQZB SQZ Biotechnologies Co Jun 14, 2023 1 $0 4 Jun 15, 2023 Director
ALNY ALNYLAM PHARMACEUTICALS, INC. Apr 26, 2023 12 -$846K 4 Apr 28, 2023 CMO & EVP Dev & Med Affairs
ALNY ALNYLAM PHARMACEUTICALS, INC. Mar 3, 2023 5 -$3.13M 4 Mar 7, 2023 CMO & EVP Dev & Med Affairs
ALNY ALNYLAM PHARMACEUTICALS, INC. Feb 27, 2023 2 $0 4 Mar 1, 2023 CMO & EVP Dev & Med Affairs
ALNY ALNYLAM PHARMACEUTICALS, INC. Aug 3, 2022 7 -$974K 4 Aug 5, 2022 CMO & EVP Dev & Med Affairs
SQZB SQZ Biotechnologies Co Jun 15, 2022 1 $0 4 Jun 16, 2022 Director
ALNY ALNYLAM PHARMACEUTICALS, INC. Feb 23, 2022 1 $0 4 Feb 25, 2022 CMO & EVP Dev & Med Affairs
ALNY ALNYLAM PHARMACEUTICALS, INC. Dec 31, 2021 0 $0 3 Jan 4, 2022 CMO & EVP Dev & Med Affairs
SQZB SQZ Biotechnologies Co Jun 15, 2021 1 $0 4 Jun 17, 2021 Director